Actavis plc., of Dublin, said it reached an agreement with Janssen Pharmaceuticals Inc. (JPI), a unit of New Brunswick, N.J.-based Johnson & Johnson, to continue supplying the authorized generic version of JPI's Concerta (methylphenidate hydrochloride extended-release tablets).